4 completed. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
Follow Systolic Murmurs: new trials by email Literature Review of Systolic Murmurs trials Research Report on Systolic Murmurs
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Human Neuregulin-1 to Treat Stable Chronic Heart Failure Placebo, rhNRG-1 Dose 1, rhNRG-1 Dose 2 - Chronic Heart Failure | Phase 2 | Completed | Zensun Sci. & Tech. Co., Ltd. | 67 | 2012-01-01 | 2025-02-10 |
| Hyperuricemia on Hypertension and Metabolic Syndrome Allopurinol, placebo - Systolic and Diastolic Blood Pressure Levels, Uric Acid Levels | Phase 2 | Completed | Instituto Nacional de Cardiologia Ignacio Chavez | 40 | 2010-07-01 | 2014-07-24 |
| Effects of Aliskiren, Ramipril, and the Combination on Levels of Angiotensin II in Patients With Decompensated Systolic Heart Failure aliskiren, ramipril, Placebo to aliskiren - Heart Failure | Phase 2 | Completed | Novartis Pharmaceuticals | 123 | 2009-05-01 | 2012-07-26 |
| Evaluation of the Effects of Carperitide in Patients With Congestive Heart Failure Carperitide, Placebo - Heart Failure, Congestive, Heart Decompensation | Phase 2 | Completed | Daiichi Sankyo | 162 | 2004-01-01 | 2016-11-08 |
Heart Failure (2) · Cardiomyopathies (1) · Hypertension (1) · Hyperuricemia (1) · Metabolic Syndrome (1) · Ventricular Dysfunction, Left (1)
Heart Murmurs (4) · Pathological Conditions, Signs and Symptoms (4) · Signs and Symptoms (4) · Cardiovascular Diseases (3) · Heart Diseases (2) · Glucose Metabolism Disorders (1) · Hyperinsulinism (1) · Insulin Resistance (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Pathologic Processes (1) · Vascular Diseases (1) · Ventricular Dysfunction (1)
Allopurinol (1) · NPPA protein, human (1) · Ramipril (1) · aliskiren (1)
Daiichi Sankyo (1) · Instituto Nacional de Cardiologia Ignacio Chavez (1) · Novartis Pharmaceuticals (1) · Zensun Sci. & Tech. Co., Ltd. (1)
United States (2) · Canada (1) · Germany (1) · Mexico (1) · Poland (1) · Russia (1)
Barry Greenberg, MD (1) · Biljana Pavlovic-Surjancev, MD, PhD (1) · Magdalena Madero, MD (1) · Uri Elkayam, MD (1)